Vitamin D receptor activators

Int J Artif Organs. 2009 Feb;32(2):101-7. doi: 10.1177/039139880903200207.

Abstract

The fields for clinical employment of vitamin D analogs are growing and under active evaluation in different medical specialties, ranging from dermatology to immunology and oncology. In this review we provide a brief description of the drugs that have been developed more specifically for the treatment of secondary hyperparathyroidism (SH) associated with uremia.

Publication types

  • Review

MeSH terms

  • Calcitriol / analogs & derivatives
  • Calcitriol / therapeutic use
  • Dihydroxycholecalciferols / therapeutic use
  • Ergocalciferols / therapeutic use
  • Humans
  • Hyperparathyroidism, Secondary / drug therapy*
  • Hyperparathyroidism, Secondary / etiology
  • Uremia / complications
  • Vitamin D / analogs & derivatives*

Substances

  • Dihydroxycholecalciferols
  • Ergocalciferols
  • Vitamin D
  • 1 alpha-hydroxyergocalciferol
  • paricalcitol
  • Calcitriol
  • 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3
  • 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol